Close Menu

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Dutch affinity purification firm BAC today announced a partnership to create HPLC columns prepacked with its Capture Select affinity ligand specificities on Life Technologies' Poros chromatography media and HPLC columns.

The columns will be designed for high pressures and flow rates, and will support Process Analytical Technology for almost any biopharmaceutical manufacturing process, BAC said.

Financial and other terms of the deal were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post writes that the approval in the US of a SARS-CoV-2 vaccine will be up to Peter Marks, a career official at the Food and Drug Administration.

According to ScienceInsider, the US National Academies of Science, Engineering, and Medicine is planning a study of racism in academic research.

NPR reports the US loan to Eastman Kodak to boost domestic pharmaceutical production is on pause following insider trading allegations.

In Cell this week: blood immune cell changes in COVID-19 patients and spatial transcriptomics in Alzheimer's disease.